MRI characteristics and histological changes in glioblastoma after gene therapy

Frontiers of Radiation Therapy and Oncology

Volumn 33, Issue , 1999, Pages 244-252

  Weber, F W ^a   Floeth, F W ^a   Reifenberger, G ^a   Felsberg, J ^a   Aulich, A ^a   Kiwit, J C W ^a   Bock, W J ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

THYMIDINE KINASE;

ADULT; AGED; ANIMAL; ARTICLE; BRAIN TUMOR; CLINICAL TRIAL; ENZYMOLOGY; FEMALE; GENE THERAPY; GENETICS; GLIOBLASTOMA; HERPES SIMPLEX VIRUS; HUMAN; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; MOLONEY LEUKEMIA ONCOVIRUS; MOUSE; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PILOT STUDY; PROSPECTIVE STUDY; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; AGED; ANIMALS; BRAIN NEOPLASMS; FEMALE; GENE THERAPY; GLIOBLASTOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MICE; MIDDLE AGED; MOLONEY MURINE LEUKEMIA VIRUS; NEOPLASM RECURRENCE, LOCAL; PILOT PROJECTS; PROSPECTIVE STUDIES; SIMPLEXVIRUS; THYMIDINE KINASE; TREATMENT OUTCOME;

EID: 0032665624     PISSN: 00719676     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000061240     Document Type: Article

References (17)

1. Radhakrishan K, Bohnen Nl, Kurland LT: Epidemiology of brain tumors; in Moraz RA, Walsh JW (eds): Brain Tumors: A Comprehensive Text. New York, 1994, pp 1-18.
2. Salcman M: Epidemiology and factors affecting survival; in Apuzzo MLJ (ed): Malignant Cerebral Glioma. Park Ridge, American Association of Neurological Surgeons, 1990, pp 95-110.
3. Werner MH, Phuphanich S, Lyman GH: The increasing incidence of malignant gliomas and primary central nervous system lymphoma in the elderly. Cancer 1995;76:1634-1642.
4. Black P: Brain tumors. N Engl J Med 1991;324:1471-1476.
5. Levin VA, Silver P, Hannigan J, Wara WH, Gutin PH, Davis RL, Wilson CB: Superiority of postradiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 Final Report. Int J Radiat Oncol Biol Phys 1990;18:321-324.
6. Levin VA, Wara WM, Davis RL, Silver P, Resser KJ, Yatsk K, Nutik S, Gutin PH, Wilson CB: NCOG protocol 6G91: Response to treatment with radiation therapy and seven-drug chemotherapy in patients with glioblastoma multiforme. Cancer Treat Rep 1986;70:739-743.
7. Phillips TL, Levin VA, Ahn DK, Gutin PH, Davis RL, Wilson CB, Prados MD, Wara WM, Flam MS: Evaluation of bromodeoxyuridine in glioblastoma multiforme: A Northern California Cancer Center phase II study. Int J Radiat Oncol Biol Phys 1991;21:709-714.
8. Ammirati M, Galicich JH, Arbit E, Liao Y: Reoperation in the treatment of recurrent intracranial malignant gliomas. Neurosurgery 1987;21:607-614.
9. Rajan B, Ross G, Lim CC, Ashley S, Goode D, Traish D, Brada M: Survival in patients with recurrent glioma as a measure of treatment efficacy: Prognostic factors following nitrosourea chemotherapy. Eur J Cancer 1994;30A:1809-1815.
10. Moolten FL: Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: Paradigm for a prospective cancer control strategy. Cancer Res 1986;46:5276-5281.
11. Plautz G, Nabel EG, Nabel GJ: Selective elimination of recombinant genes in vivo with a suicide retroviral vector. New Biol 1991;3:709-715.
12. Borrelli E, Heyman R, Hsi M, Evans RM: Targeting of an inducible toxic phenotype in animal cells. Proc Natl Acad Sci USA 1988;85:7572-7576.
13. Ezzedine ZD, Martuza RL, Platika D, Short MP, Malick A, Choi B, Breakefield XO: Selective kitling of glioma cells in culture and in vivo by retrovirus transfer of the herpes simplex thymidine kinase gene. New Biol 1991;3:608-614.
14. Moolten FL, Wells JM: Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors. J Natl Cancer Inst 1990;B2:297-300.
15. Cornetta K, Morgan RA, Anderson WF: Safety issues related to retroviral-mediated gene transfection in humans. Hum Gene Ther 1991;2:5-14.
16. Anderson WF, McGarrity GJ, Moen RC: Report to NIH Recombinant DNA Advisory Committee on Murine Replication-Competent Retrovirus Assays (Feb 17, 1993). Hum Gene Ther 1993;4:311-321.
17. Ram Z, Culver KW, Oshiro EM, Viola JJ, DeVroom HL, Otto E, Long Z, Chiang Y, McGarrity GJ, Muul LM,Katz D, Blaese RM, Oldfield EH: Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells. Nat Med 1997;3/12:1354-1361.